Synairgen

Synairgen is a respiratory drug discovery and development company founded by University of Southampton professors Stephen Holgate, Donna Davies, and Ratko Djukanovic. It primarily focuses on lung viral defense in asthma and COPD, leveraging its distinctive human biology BioBank platform and a world-renowned international academic KOL network to discover and develop new therapies for respiratory diseases.